MedTrace Logo

Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma

NCT04276025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-02-19

No results posted yet for this study

Summary

Retrospective study in patients with therapy-naive non small cell lung carcinoma correlating presurgical F18-FDG-PET/CT imaging texture analysis data with postsurgical molecular pathology data and clinical patient outcome. Main aim is to identify pretherapeutic prognostic factors.

Conditions

Interventions

OTHER

Clinical routine F18-FDG-PET/CT, molecular pathology and clinical outcome

Retrospective analysis of clinical routine F18-FDG-PET/CT, molecular pathology and clinical outcome data.

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    collaborator OTHER

  • Sana Klinikum Hof

    collaborator UNKNOWN

  • Klinikum Bayreuth GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2020-01-31
Completion
2020-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04276025 on ClinicalTrials.gov